- Company to accelerate industrial scale-up of its high-performance bio-based silk polymers and expand commercial operations into new markets
- This is the 12th investment in bioindustrials by Novo Holdings
Copenhagen, Denmark, 11 May 2021 – Novo Growth, the growth equity arm of Novo Holdings, today announced that it has led a EUR 29 million series C investment in AMSilk, the world’s first industrial supplier of synthetic silk biopolymers. The financing also included new investors Cargill and E.R. Capital Holdings as well as existing investors MIG Verwaltungs AG and ATHOS KG. Kartik Dharmadhikari, Partner and Anders Bendsen Spohr, Senior Partner at Novo Holdings will join the Supervisory Board.